Filing Details

Accession Number:
0001104659-22-084316
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-07-29 17:02:07
Reporting Period:
2022-07-27
Accepted Time:
2022-07-29 17:02:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1736243 Acurx Pharmaceuticals Inc. ACXP Pharmaceutical Preparations (2834) DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1127423 J Robert Deluccia C/O Acurx Pharmaceuticals, Inc.,
259 Liberty Avenue
Staten Island NY 10305
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-07-27 19,737 $3.80 1,051,198 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrants for Common Stock Acquisiton 2022-07-27 19,737 $0.00 19,737 $3.55
Common Stock Warrants for Common Stock Acquisiton 2022-07-27 19,737 $0.00 19,737 $3.55
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
19,737 2023-01-27 2024-01-27 No 4 P Direct
19,737 2023-01-27 2028-01-27 No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 3,847 Indirect By spouse